Product Name
CYP11B1/2, Polyclonal Antibody
Full Product Name
CYP11B1/2 Polyclonal Antibody
Product Synonym Names
CYP11B1; S11BH; Cytochrome P450 11B1, mitochondrial; CYPXIB1; Cytochrome P-450c11; Cytochrome P450C11; Steroid 11-beta-hydroxylase; CYP11B2
Product Gene Name
anti-CYP11B1/2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P15538
Specificity
CYP11B1/2 Polyclonal Antibody detects endogenous levels of CYP11B1/2 protein.
Purity/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Form/Format
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Concentration
1 mg/ml (lot specific)
Immunogen Description
Synthesized peptide derived from the N-terminal region of human CYP11B1/2.
Preparation and Storage
Store at -20 degree C/1 year
Other Notes
Small volumes of anti-CYP11B1/2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-CYP11B1/2 antibody
Total protein Ab
Applications Tested/Suitable for anti-CYP11B1/2 antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-CYP11B1/2 antibody
Western Blot: 1:500 - 1:2000
ELISA: 1:20000
Not yet tested in other applications.
Western Blot (WB) of anti-CYP11B1/2 antibody
Western Blot analysis of HT29 HuvEc K562 cells using CYP11B1/2 Polyclonal Antibody

NCBI/Uniprot data below describe general gene information for CYP11B1/2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000488.3
[Other Products]
NCBI GenBank Nucleotide #
NM_000497.3
[Other Products]
UniProt Primary Accession #
P15538
[Other Products]
UniProt Secondary Accession #
Q14095; Q4VAQ8; Q4VAQ9; Q9UML2[Other Products]
UniProt Related Accession #
P15538[Other Products]
Molecular Weight
49,750 Da
NCBI Official Full Name
cytochrome P450 11B1, mitochondrial isoform 1
NCBI Official Synonym Full Names
cytochrome P450, family 11, subfamily B, polypeptide 1
NCBI Official Symbol
CYP11B1??[Similar Products]
NCBI Official Synonym Symbols
FHI; CPN1; CYP11B; P450C11
??[Similar Products]
NCBI Protein Information
cytochrome P450 11B1, mitochondrial
UniProt Protein Name
Cytochrome P450 11B1, mitochondrial
UniProt Synonym Protein Names
CYPXIB1; Cytochrome P-450c11; Cytochrome P450C11; Steroid 11-beta-hydroxylase (EC:1.14.15.4)
UniProt Gene Name
CYP11B1??[Similar Products]
UniProt Synonym Gene Names
S11BH; Cytochrome P450C11??[Similar Products]
UniProt Entry Name
C11B1_HUMAN
NCBI Summary for CYP11B1/2
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
UniProt Comments for CYP11B1/2
CYP11B1: Has steroid 11-beta-hydroxylase activity. In addition to this activity, the 18 or 19-hydroxylation of steroids and the aromatization of androstendione to estrone have also been ascribed to cytochrome P450 XIB. Defects in CYP11B1 are the cause of adrenal hyperplasia type 4 (AH4). AH4 is a form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short ***** stature. Four clinical types: salt wasting (SW, the most severe type), simple virilizing (SV, less severely affected patients), with normal aldosterone biosynthesis, non-classic form or late onset (NC or LOAH), and cryptic (asymptomatic). AH4 patients usually have hypertension. Defects in CYP11B1 are a cause of familial hyperaldosteronism type 1 (FH1). It is a disorder characterized by hypertension, variable hyperaldosteronism, and abnormal adrenal steroid production, including 18-oxocortisol and 18-hydroxycortisol. There is significant phenotypic heterogeneity, and some individuals never develop hypertension. The molecular defect causing hyperaldosteronism familial type 1 is an anti-Lepore-type fusion of the CYP11B1 and CYP11B2 genes. The hybrid gene has the promoting part of CYP11B1, ACTH-sensitive, and the coding part of CYP11B2. Belongs to the cytochrome P450 family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Oxidoreductase; Lipid Metabolism - C21-steroid hormone; Mitochondrial; Lipid Metabolism - androgen and estrogen; EC 1.14.15.4
Chromosomal Location of Human Ortholog: 8q21
Cellular Component: mitochondrion; mitochondrial inner membrane
Molecular Function: steroid 11-beta-monooxygenase activity; iron ion binding; heme binding
Biological Process: steroid metabolic process; regulation of blood pressure; xenobiotic metabolic process; C21-steroid hormone biosynthetic process; immune response; glucocorticoid biosynthetic process; glucose homeostasis; sterol metabolic process; aldosterone biosynthetic process; cellular response to hormone stimulus
Disease: Adrenal Hyperplasia, Congenital, Due To Steroid 11-beta-hydroxylase Deficiency; Glucocorticoid-remediable Aldosteronism
Research Articles on CYP11B1/2
1. Mutations in the CYP11B1 gene are the cause of 11beta-hydroxylase deficiency.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.